or reference product on the discontinued products list and the manufacturer marketed or sold a follow-on product. (ii) (I) The manufacturer of the listed drug or reference product— (aa) announced withdrawal of, discontinuance of the manufacture of, or intent to withdraw the application with respect to the drug or reference product in a manner that impedes competition from a generic drug or a biosimilar biological product, as established by objective circumstances